Filtros de búsqueda

Lista de obras de

Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia

artículo científico publicado en 2018

Characteristics of long-term survivors with multiple myeloma: A National Cancer Data Base analysis

artículo científico publicado en 2019

Daratumumab-based therapy in patients with heavily-pretreated AL amyloidosis

artículo científico publicado en 2018

Dexamethasone, rituximab and cyclophosphamide for relapsed and/or refractory and treatment-naïve patients with Waldenstrom macroglobulinemia

artículo científico

Efficacy of daratumumab-based therapies in patients with relapsed, refractory multiple myeloma treated outside of clinical trials

artículo científico publicado en 2017

Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes

scientific article published on 29 August 2019

Impact of MYD88L265P mutation status on histological transformation of Waldenström Macroglobulinemia

scientific article published on 31 December 2019

Implications of detecting serum monoclonal protein by MASS-fix following stem cell transplantation in multiple myeloma

artículo científico publicado en 2020

MYD88 mutation status does not impact overall survival in Waldenström macroglobulinemia.

artículo científico publicado en 2017

Non-Hodgkin lymphoma presenting as acute pancreatitis: A rare occurrence

scientific article published on 20 November 2018

Outcome of very young (≤40 years) patients with immunoglobulin light chain (AL) amyloidosis

POEMS syndrome: An elusive diagnosis.

artículo científico publicado en 2017

Partial response or better at six months is prognostic of superior progression-free survival in Waldenström macroglobulinaemia patients treated with ibrutinib

artículo científico publicado en 2020

Pompe Disease Could Mimic Exam Findings of Amyloidosis: Two Rare Diagnoses Bona Fide

scientific article published on 28 October 2018

Predictors of short-term survival in Waldenström Macroglobulinemia

artículo científico publicado en 2020

Predictors of symptomatic hyperviscosity in Waldenström macroglobulinemia

scientific article published on 02 October 2018

Primary systemic amyloidosis in patients with Waldenström macroglobulinemia

artículo científico publicado en 2018

Reply to Castillo et al.

artículo científico publicado en 2018

Treatment facility volume and patient outcomes in Waldenstrom macroglobulinemia

scientific article published on 15 October 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda